Scientists gave six healthy men a single dose of oral ainuovirine to see how the body handles it. They tracked the drug for ten days to understand its journey through the system. The team wanted to know exactly where the medicine went and how it left the body. This kind of testing helps doctors decide if a drug is safe and effective for people with HIV-1.
The drug entered the bloodstream quickly, reaching peak levels in about three and a half hours. Most of the medicine left the body unchanged, with over sixty percent exiting through urine and faeces. The rest was processed by the liver before leaving the body. This tells us the drug does not build up dangerously in the system over time.
No safety problems appeared during the short testing period. The men tolerated the medicine well without needing to stop the trial early. While this study only looked at healthy men, the results support using ainuovirine as a strong option for treating HIV-1. The data shows the drug works as expected and leaves the body cleanly.